KalVista Pharmaceuticals Inc. (KALV) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    KalVista Pharmaceuticals ...

    NASDAQ: KALV · Real-Time Price · USD
    11.85
    0.10 (0.85%)
    At close: Oct 03, 2025, 3:59 PM
    12.05
    1.69%
    After-hours: Oct 03, 2025, 07:49 PM EDT

    KalVista Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
    Cash & Equivalents
    		 98.64M 31.79M 56.24M 30.73M 50.59M
    Short-Term Investments
    		 89M 178.61M 93.14M 135.47M 198.34M
    Long-Term Investments
    		 n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 7.09M 567K 106K 193K 200K
    Receivables
    		 15.14M 10.87M 16.57M n/a 10.42M
    Inventory
    		 n/a n/a n/a 2.71M n/a
    Other Current Assets
    		 19.21M n/a n/a n/a n/a
    Total Current Assets
    		 241.69M 225.69M 172.33M 193.65M 264.26M
    Property-Plant & Equipment
    		 1.99M 9.15M 10.77M 10.04M 7.55M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 9.08M 9.71M 10.88M 10.23M 7.75M
    Total Assets
    		 250.77M 235.4M 183.2M 203.88M 272.01M
    Account Payables
    		 4.88M 9.11M 4.82M 3.64M 1.98M
    Deferred Revenue
    		 11M n/a n/a n/a n/a
    Short-Term Debt
    		 1.98M n/a n/a n/a n/a
    Other Current Liabilities
    		 -1.98M 6.69M n/a n/a n/a
    Total Current Liabilities
    		 45.17M 22.81M 15.03M 11.58M 9.77M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 110.21M 6.01M 7.14M 7.21M 5.05M
    Total Liabilities
    		 155.38M 28.82M 22.18M 18.79M 14.82M
    Total Debt
    		 6.31M 7.32M 8.23M 8.19M 5.91M
    Book Value
    		 95.39M 206.58M 161.03M 185.09M 257.19M
    Book Value Per Share
    		 1.92 5.62 5.77 7.56 13.47
    Common Stock
    		 50K 42K 34K 25K 24K
    Retained Earnings
    		 -653.17M -469.73M -343.08M -250.18M -167.84M
    Comprehensive Income
    		 -5.21M -3.49M -3.06M -3.86M -1.43M
    Shareholders Equity
    		 95.39M 206.58M 161.03M 185.09M 257.19M
    Total Investments
    		 89M 178.61M 93.14M 135.47M 198.34M

    Add to Watchlist